Ibrutinib repurposing: from B-cell malignancies to solid tumors

Oncoscience. 2016 Jun 10;3(5-6):147-8. doi: 10.18632/oncoscience.310. eCollection 2016.

¹ Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
² Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.

No abstract available

Keywords: BTK; drug repurposing; ibrutinib; inflammation; solid tumors.